Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Japanese Cayratia Herb enema plus mesalazine for ulcerative colitis
TCTR20230913006Phase 3Completed
- Sponsor
- Lijiang Jishi Pharmaceutical
- Start
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Salcrozine in autoimmune colitis, sponsored by Lijiang Jishi Pharmaceutical. Started May 2022; status: completed.
02
Drugs
Salcrozine
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on TCTR20230913006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230913006.